Email this page

Mandatory fields are marked with an asterisk [*].

Fill in your email details
1. * Your name:
2. * Your email address:
3. * Recipient name:
4. * Recipient email address:
Note: Smith & Nephew does not collect or make use of the email addresses or names provided here. They are only used to show the recipient who has sent the message.
Change the message if you want to
1. To: <recipient name> <address>
2. From: <sender name> <address>
3. Subject: <sender name> is sending you a link
4. Hi,
  I saw this on the Smith & Nephew site and thought you might be interested.
5. <sender name>

Company Information

Quarterly Corporate Fact Sheet

Download as pdf
(PDF - 1149.67 KB)

What we do

What we do
Smith & Nephew's four Global Business Units are at the forefront of innovation to benefit our customers and their patients.

Who we are

Who we are
Smith & Nephew develops and markets advanced medical devices that help healthcare professionals treat patients more effectively – and patients get back to their normal lives faster

Generating annual sales of $2.8 billion - Smith & Nephew helps patients all over the world get back to their normal lives after illness or injury.

The Orthopaedic Reconstruction and Orthopaedic Trauma and Clinical Therapies businesses are headquartered in Memphis, Tennessee, which is also the site of the main manufacturing facility. Orthopaedic reconstruction and trauma products are also manufactured in Tuttlingen, Germany and Warwick, UK. The Endoscopy business is based in the suburbs of Boston, Massachusetts. The Advanced Wound Management business is headquartered in Hull, England.

Smith & Nephew focuses its efforts on major markets that offer significant growth potentialr. These are driven primarily by the dual drivers of favourable demographics, expanding markets through technological advances and increasingly active lifestyles. Every day, the company helps people get back to their normal lives by developing and delivering new and innovative technologies that lead to more effective treatments.

Substantial investment in our products and intensive research and development means that we are always ahead. Figures from last year show that we stand at number one as the leading company in Arthroscopy. We are the second largest organisation in Advanced Wound Management as well as in Trauma and Clinical Therapies. We are also positioned at number six in reconstruction.

The primary factors supporting this long term growth and success of Smith & Nephew include:

Leadership in markets with sustained long-term growth potential
No. 1 global market share in arthroscopy (sports medicine)
Leadership position in Advanced Wound Management
Strong position and growing market share in Orthopaedics
Increasing expectations that people will live active lives, for longer
Innovative technologies that expand the market
Clear focus on margin expansion
Robust organic growth
Partnerships and technology/bolt-on acquisitions